Zheng Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zheng Wei has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Fenglan Pang
Harbin Institute of Technology 1 Center for Bioinformatics, School of Life Science and Technology Harbin, China
1 shared publication - Guangfu Xue
Harbin Institute of Technology 1 Center for Bioinformatics, School of Life Science and Technology Harbin, China
1 shared publication - Haoxiu Sun
Harbin Medical University 2 School of Interdisciplinary Medicine and Engineering Harbin, China
1 shared publication - Jing Ma
Harbin Medical University 2 School of Interdisciplinary Medicine and Engineering Harbin, China
1 shared publication - Jinhao Que
Harbin Institute of Technology 1 Center for Bioinformatics, School of Life Science and Technology Harbin, China
1 shared publication - Jinwei Zhang
Harbin Institute of Technology 1 Center for Bioinformatics, School of Life Science and Technology Harbin, China
1 shared publication
Latest Publications
- 30 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- p. OF1-OF12
ScanTCR Enables Early Cancer Detection by Repertoire-Scale Representation of Cancer-Associated T-cell Receptors in Peripheral Blood
T cells initiate anticancer immune responses at an early stage of tumorigenesis, thus enabling dynamic monitoring of peripheral blood T-cell receptor (TCR) repertoire changes as a promising strategy for early cancer detection. However, the current TCR-based cancer detection methods focus on limited high-frequency TCRs instead of repertoire-scale representation, overlooking numerous crucial cancer-associated TCRs (caTCR). Herein, we developed ScanTCR, a computational framework for early cancer detection that introduces a reference-guided repertoire-scale encoding method capable of incorporating all TCRs. ScanTCR exhibited remarkable precision in distinguishing patients with cancer from noncancer individuals using peripheral blood TCRs. In a pan-cancer analysis encompassing seven cancer types, ScanTCR demonstrated robust performance in detecting both cancer types included in the training data and unseen cancer types, surpassing state-of-the-art TCR-based methods. Furthermore, ScanTCR identified caTCRs in which corresponding T cells exhibit enhanced cellular immune capacity. Collectively, this work proposes a TCR-based approach enabling repertoire-scale representation of immune receptors for noninvasive early cancer detection. Significance: Overcoming limitations of current methods that favor high-frequency cancer-associated T-cell receptors, repertoire-scale profiling preserves all sequences for accurate cancer detection, supporting the potential of this approach for early-stage cancer diagnostics.
- 30 October 2026
- Published by American Association for Cancer Research (AACR) in Cancer Research
- p. OF1-OF12
ScanTCR Enables Early Cancer Detection by Repertoire-Scale Representation of Cancer-Associated T-cell Receptors in Peripheral Blood
T cells initiate anticancer immune responses at an early stage of tumorigenesis, thus enabling dynamic monitoring of peripheral blood T-cell receptor (TCR) repertoire changes as a promising strategy for early cancer detection. However, the current TCR-based cancer detection methods focus on limited high-frequency TCRs instead of repertoire-scale representation, overlooking numerous crucial cancer-associated TCRs (caTCR). Herein, we developed ScanTCR, a computational framework for early cancer detection that introduces a reference-guided repertoire-scale encoding method capable of incorporating all TCRs. ScanTCR exhibited remarkable precision in distinguishing patients with cancer from noncancer individuals using peripheral blood TCRs. In a pan-cancer analysis encompassing seven cancer types, ScanTCR demonstrated robust performance in detecting both cancer types included in the training data and unseen cancer types, surpassing state-of-the-art TCR-based methods. Furthermore, ScanTCR identified caTCRs in which corresponding T cells exhibit enhanced cellular immune capacity. Collectively, this work proposes a TCR-based approach enabling repertoire-scale representation of immune receptors for noninvasive early cancer detection. Significance: Overcoming limitations of current methods that favor high-frequency cancer-associated T-cell receptors, repertoire-scale profiling preserves all sequences for accurate cancer detection, supporting the potential of this approach for early-stage cancer diagnostics.